What VProteomics does

VProteomics is a New Delhi/Noida, India-based mass spectrometry services provider founded in 2016 that delivers proteomics, metabolomics, clinical mass spectrometry, and biologics characterization to academic research institutions, hospitals/clinical laboratories, and pharmaceutical/biotech companies across India. The company operates a centralized lab equipped with Thermo Scientific Orbitrap Exploris and Orbitrap Fusion series mass spectrometers, Triple Quadrupole MS systems (Thermo/Waters), Agilent GC-MS, and nano-LC workflows; it has developed proprietary sample-preparation and TiO2-based phosphoproteomics enrichment protocols yielding 5,000–6,000 protein identifications per run and sub-femtomole limits of detection.

Its service portfolio is organized into branded product lines: VPGEL (gel-based proteomics with PTM analysis), VPSOL (solution-based global proteomics with quantitative workflows including LFQ, SILAC, ICAT, iTRAQ/TMT, and DIA), VPMETA (discovery and targeted metabolomics via HRAM MS with statistical pipelines), VP-CLIN (clinical assays including vitamin D at LOQ 1 ng/ml, steroid panels, TDM, and plasma proteomics biomarker studies), and biologics characterization (intact mass with ±0.01% accuracy, peptide mapping, N/C-terminal sequencing for mAbs and ADCs). The data analysis layer combines commercial and open-source search engines with R-based statistical workflows and high-performance computing infrastructure.

VProteomics monetizes through project-based professional services fees negotiated per engagement, with pricing determined by sample count, complexity, technology requirements, and analytical deliverables; the company describes multi-year contract cadences. Go-to-market is consultative and enterprise-field-sales oriented, engaging principal investigators, clinicians, and pharma R&D teams from project design through data delivery, with sample logistics including dry-ice pickup coordination. The company holds equipment-vendor relationships with Thermo Scientific, Waters, and Agilent, and since 2020 has operated a joint-marketing model with technology partners; since 2023 it has partnered with clinical labs to deliver hospital testing. No external funding rounds have been disclosed, and the company remains privately held and founder-operated.

Name

VProteomics

Legal name

VProteomics

Website

https://www.vproteomics.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

VProteomics is a New Delhi-based mass spectrometry services provider delivering proteomics, metabolomics, clinical MS, and biologics characterization to academic, hospital, and pharmaceutical clients across India. It operates Orbitrap and Triple Quadrupole platforms with proprietary sample-prep and data-analysis pipelines.

Ownership category

akta.pro rank

Product category

Proteomics and Mass Spectrometry Services

NAICS

Scientific Research and Development Services (5417), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Proteomics & Mass Spectrometry Services (HLAGANAB)

akta.pro secondary industries

Metabolomics & Lipidomics Services (HLAGANAG), Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB), Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)

Keywords

• Mass spectrometry services
• Proteomics analysis
• Metabolomics services
• Biologics characterization
• Clinical mass spectrometry

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Proteomics Services: Project-based proteomics analysis services including gel-based (VPGEL) and solution-based (VPSOL) protein identification, PTM analysis, and quantitative proteomics. Revenue generated through per-project fees based on sample complexity, number of samples, and analysis requirements.
2. Metabolomics Services: Discovery and targeted metabolomics services (VPMETA) using HRAM mass spectrometry. Revenue generated through analytical services for metabolite identification and quantification projects.
3. Clinical Mass Spectrometry: Clinical diagnostic services including vitamin D testing, steroid panel screening, therapeutic drug monitoring, and plasma proteomics biomarker studies for hospital and clinical research clients.
4. Biologics Characterization: Services for biopharmaceutical characterization including intact mass analysis, peptide mapping, and N/C-terminal sequencing for monoclonal antibodies and protein therapeutics QA/QC.
5. Facility Management Services: Project designing and facility management consulting services for organizations establishing mass spectrometry capabilities, started in 2019.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

VProteomics provides mass spectrometry-based proteomics, metabolomics, clinical research, and biologics characterization services from its lab in Noida, India. The company delivers project-based analytical services using Orbitrap Exploris/Fusion and Triple Quadrupole mass spectrometers, supporting academic, clinical, and pharmaceutical clients across India with end-to-end project support from experimental design through data analysis and publication/regulatory reporting.

Product overview

VProteomics offers a comprehensive suite of mass spectrometry-based proteomics and metabolomics services delivered through distinct product lines. The core offerings include VPGEL LC-MS/MS for gel-based protein identification, VPSOL LC-MS/MS for solution-based proteomics, VPMETA LC-MS/MS for discovery and targeted metabolomics, VP-CLIN LC-MS/MS for clinical diagnostics, and Biologics Characterization Services for biopharmaceutical analysis. These are supported by specialized modules for quantitative proteomics (SILAC, ICAT, iTRAQ/TMT, label-free), data independent acquisition (DIA), targeted SRM/PRM analysis, phosphoproteomics with TiO2 enrichment, interactomics for protein-protein interactions, and PTM analysis. The services utilize Orbitrap Exploris and Fusion series mass spectrometers combined with nano-ESI LC-MS/MS workflows to deliver protein identification, quantification, and characterization to academic, clinical, and pharmaceutical clients in India.

Differentiator

Problem solved

Functional benefit

Brands

• VPGEL LC-MS/MS: Gel-based protein identification service using 1D or 2D gel bands/spots with MS compatible staining methods.
• VPSOL LC-MS/MS
• VPMETA LC-MS/MS
• VP-CLIN LC-MS/MS
• Intact Mass Analysis
• Peptide Mapping

Products and services

• Discovery & Targeted Proteomics Services Mass spectrometry-based proteomics services including gel-based (VPGEL) protein identification from 1D/2D gel bands, solution-based (VPSOL) global proteome analysis identifying 5000-6000 proteins per run, quantitative proteomics (LFQ, SILAC, ICAT, iTRAQ/TMT), DIA workflows, SRM/PRM targeted validation, phosphoproteomics with TiO2 enrichment, interactomics (AP-MS), and PTM analysis (phosphorylation, methylation, acetylation, ubiquitination, nitrosylation, disulfide bonds). Designed for academic researchers, pharma, and biotech clients in India.
• Advanced Metabolomics Services Discovery and targeted metabolomics services (VPMETA) using high-resolution accurate mass (HRAM) mass spectrometers with retention time corrections, elemental formula prediction, feature detection, and statistical analysis (PCA, PLS-DA, ANOVA, t-tests). Includes discovery metabolomics (VP-DEEPMETABO1/2) and targeted SRM/PRM metabolomics (VP-TAR-MET) for biomarker identification and metabolic pathway analysis. Targeted at academic researchers, clinical researchers, and pharma clients.
• Clinical Mass Spectrometry Services Clinical mass spectrometry (VP-CLIN) for diagnostic purposes including plasma proteomics/biomarker studies, vitamin D estimation using LC-MS/MS gold standard (LOQ to 1 ng/ml), steroid panel screening, therapeutic drug monitoring for metabolism deficiencies, and toxicology testing. Targeted at hospitals, clinical research organizations, and medical laboratories in India.
• Biologics Characterization Services Comprehensive characterization of biomolecules for biopharmaceutical clients including intact mass analysis (molecular weight accuracy better than ±0.01%), peptide mapping for primary structural characterization of monoclonal antibodies and antibody-drug conjugates, and N-terminal/C-terminal sequencing for protein therapeutics QA/QC and biosimilar comparability studies. Targeted at pharmaceutical and biotech companies in India.
• Facility Management Services Project designing and facility management consulting services for organizations looking to establish in-house mass spectrometry capabilities, including technology selection, workflow design, and operational setup guidance. Targeted at academic institutions and pharma/biotech companies building internal MS infrastructure in India.

Quantifiable outcome

• 5000-6000 proteins routinely identified in a single DDA or DIA mass spec run
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Five partnerships are on record, tiered core and supporting.

• Partner Labs (Clinical Testing)coreStrategic or Co-development Partner · 1 January 2023In 2023, VProteomics started targeted clinical testing using QQQ and Orbitrap platforms with partner labs for hospital client services. This enables expanded clinical testing capabilities and market reach.
• Technology PartnerscoreTechnology or Integration · 1 January 2020In 2020, VProteomics started a joint marketing model of advanced scientific services with suitable technology partners. These partnerships enable access to latest mass spectrometry equipment and methodologies from major vendors.
• Thermo ScientificcoreTechnology or IntegrationEquipment vendor for Orbitrap Exploris and Orbitrap Fusion mass spectrometers, Triple Quadrupole MS systems. The company's service capabilities are built on Thermo Scientific instrumentation.
• WaterssupportingTechnology or IntegrationEquipment vendor for Triple Quadrupole MS systems used in targeted metabolomics and clinical applications.
• AgilentsupportingTechnology or IntegrationEquipment vendor for GC-MS applications in gas chromatography-based analyses.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Cell Signaling Technology (CST): US-based antibody and proteomics company offering phosphoproteomics and PTM-focused MS services alongside its antibody catalog. Overlaps in phosphoproteomics, PTM analysis, and targeted proteomics for academic and pharma researchers.
• Biognosys: Swiss-based contract proteomics services company offering discovery proteomics, DIA workflows, and targeted proteomics using Orbitrap instrumentation. Closest direct competitor in technology stack and service model, though operating primarily in US/Europe rather than India.
• Proteome Sciences: UK-listed proteomics services company specializing in MS-based protein analysis for pharma and academic clients, including PTM and biomarker work. Comparable in service scope (proteomics, clinical biomarkers, biopharma) and consultative engagement model.

Regional players

• BGI Genomics: China-headquartered genomics and proteomics services giant with extensive Asia-Pacific footprint. Comparable in offering multi-omics services (genomics, proteomics, metabolomics) to academic and clinical customers, though at vastly greater scale and from a different primary geography.

Broad incumbents

• SCIEX: Major mass spectrometry instrumentation vendor (Triple Quad and QTOF systems) that also offers application support and proteomics/metabolomics services via its Sciex Services and OS-Q offerings. Comparable on instrumentation stack and adjacent on services.
• Bruker: Leading mass spectrometry and proteomics instrumentation company (timsTOF, timsTOF Pro 2, Astral co-marketing) with growing proteomics services capability via Bruker Biopharma Solutions. Directly comparable in serving the proteomics and biopharma characterization markets with overlapping instrumentation.
• WuXi AppTec: Global CRO with extensive biologics characterization and bioanalytical services including intact mass, peptide mapping, and clinical biomarker assays. Overlaps with VProteomics' biologics characterization and clinical mass spectrometry offerings, especially for biopharma clients.
• Eurofins Scientific: Global leader in bioanalytical and clinical testing services with growing proteomics and mass spectrometry capabilities across multiple geographies. Comparable in offering clinical mass spec, biomarker assays, and pharma QA/QC services to enterprise customers.
• SGS Life Sciences: Global testing and contract research services provider with bioanalytical, biologics characterization, and clinical research capabilities. Comparable in serving biopharma clients with QA/QC-focused MS services, though at significantly larger scale and broader scope.

Others

• Thermo Fisher Scientific:

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/vproteomics
• Facebookfacebook.com/vproteomics
• LinkedInlinkedin.com/company/vproteomics
• Instagraminstagram.com/vproteomics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VProteomics